Christopher B. COOPER,Haihong HUANG,Dongfeng ZHANG,Nader FOTOUHI,Takushi KANEKO
申请号：
US16740660
公开号：
US20200148651A1
申请日:
2020.01.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
